Wikipedia -WSS

Wikipedia

author：knowledge 2025-10-01 04:13:05 - browse：158

Earlier this month, Intellia Therapeutics announced it was scrapping plans to include U.S.-based sites in one of its mid-stage CRISPR trials after the Food and Drug Administration requested additional data to support including female patients of childbearing potential. The move left many researchers wondering whether the specter of accidental germline transmission — which haunted early gene therapy trials — had now risen over the field of gene editing.

Over the weekend, Intellia sought to assure the gene editing community that no such thing is happening. At a meeting at Cold Spring Harbor Laboratory that drew more than 400 of the field’s top scientists, the company shared more detailed information about studies it has conducted to assess the risks that renegade CRISPR components could be getting into an egg or sperm. These studies demonstrate “that there’s no evidence of vertical germline transmission of those edits,” Jonathan Phillips, head of pharmacology and toxicology at Intellia, said during a presentation Saturday.

Intellia is one of the leading companies working to advance in vivo gene editing therapies. In a landmark study published in the New England Journal of Medicine in 2021, Intellia revealed data from six patients in its trial for a transthyretin amyloidosis therapy — showing for the first time that it was possible to precisely alter the DNA of particular cells within the human body to treat disease with a one-time infusion of CRISPR. Included in the supplementary material was a redacted version of the company’s package requesting authorization to start its clinical trial. It noted that during toxicology studies in non-human primates, Intellia scientists discovered that editing had taken place at low levels in organs other than the liver, including the spleen and adrenal glands. In three out of 12 female monkeys, they also found editing in the animals’ ovaries.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Judge rejects Trump's request to move Stormy Daniels hush

knowledge

focus

WSS

Ohioans vote in high

Judge rejects Trump's request to move Stormy Daniels hush

Public funding for King Charles III and royals has been recalculated due to windfarm deal profits

Trump attorney outlines possible Jan. 6 legal defenses, but some experts are skeptical

Astronauts get first look at the spacecraft that will fly them around the moon

Vir antibody drug aimed at influenza A fails in clinical trial

leisure time

Wikipedia

knowledge

Hollywood unions extend contract negotiations for actors

Astronauts get first look at the spacecraft that will fly them around the moon

Virginia high school admissions case could be legal follow

'Of course' Trump lost the 2020 election, DeSantis says after years of hedging

Medical leaders decry Supreme Court decision on affirmative action

Cheesesteak restaurant owner explains his secret sauce, the viral Malibu Barbie Dream Drizzle

The high cost of giving birth even with insurance

Sage's campaign to raise awareness of postpartum depression hits a nerve

ChatGPT in medicine: STAT answers readers' burning questions

Travel bans should be based on evidence, not politics or fear

knowledge

Affordable Connectivity Program vital to health care, experts say

I learned firsthand about improving diversity in clinical trials

Wegovy cuts risk of cardiovascular events by 20%, study finds

Driven by the pandemic, applicants flood public health schools

FTX founder Sam Bankman

Can Threads overtake X, formerly known as Twitter? Experts weigh in.

knowledge

focus

focus

leisure time